HB 1009 – MarylandStatus: Inactive / Dead
Year Introduced: 2022
Altering the application of the prohibition on pharmacy benefits managers reimbursing a pharmacy or pharmacist in an amount less than the pharmacy benefits manager reimburses itself or an affiliate; repealing provisions of law relating to maximum allowable cost pricing, disputes regarding cost pricing, and reimbursement and fee for performance-based reimbursement; altering how a pharmacy benefits manager may determine reimbursement for a pharmacy or pharmacist; etc.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.